Otsuka, JP3188220002

Otsuka Holdings stock gets an FDA submission update on October 7, 2026

Published on 10/08/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Otsuka Holdings stock was at JPY 11,640 on October 8, 2026, up 1.44 percent in Tokyo. Q2 revenue reached JPY 702.05 billion, up 17.4 percent year over year.

Otsuka, JP3188220002, Illustration mit AI erstellt.

Otsuka Holdings stock (ISIN JP3188220002) was trading at JPY 11,640 on the Tokyo Stock Exchange on October 8, 2026, up JPY 165 or 1.44 percent. On October 7, 2026, MT Newswires reported through Futu that an Otsuka subsidiary initiated a US FDA submission for a kidney disease drug.

FDA filing adds a clinical catalyst

The October 7 report gives Otsuka another regulatory milestone alongside its established pharmaceutical portfolio. The company develops medicines across psychiatry, neurology, oncology, cardiovascular and renal diseases, while also operating nutraceutical and consumer businesses.

The submission matters because kidney treatments are already a growth area for Otsuka. The company has reported recent activity in renal medicine, including products and development programs aimed at preserving kidney function and expanding treatment options.

Second-quarter revenue rose 17.4 percent

Otsuka's quarter ended June 30, 2026 produced revenue of JPY 702.05 billion, compared with JPY 597.93 billion in the year-earlier quarter, according to The Globe and Mail. Net profit increased to JPY 117.26 billion from JPY 88.53 billion, a 32.5 percent year-over-year gain.

The earnings comparison gives the regulatory news financial context: revenue growth was accompanied by faster net-profit growth. Otsuka's next earnings report is scheduled for October 30, 2026, according to Investing.com.

Consensus target remains above JPY 14,000

The same Investing.com overview lists a Strong Buy consensus from 12 analysts. The average 12-month target is JPY 14,933.3, with estimates ranging from JPY 11,500 to JPY 18,600.

For investors, the key test is whether regulatory progress can extend the earnings momentum shown in the June quarter. The current price remains JPY 1,293.3 below the consensus average target, while the 52-week range runs from JPY 7,756 to JPY 12,795.

Otsuka stock trades near its yearly high

Otsuka Holdings was last at JPY 11,640 in Tokyo on October 8, 2026, at 2:42 p.m. JST. Its market capitalization was JPY 6.1 trillion and trading volume was 535,000 shares at that time.